-
ACTU Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Actuate Therapeutics (ACTU)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.52 mm | 13.52 mm | 13.52 mm | |||
Cash burn (monthly) | (no burn) | 1.80 mm | 64.65 k | |||
Cash used (since last report) | n/a | 7.23 mm | 260.02 k | |||
Cash remaining | n/a | 6.29 mm | 13.26 mm | |||
Runway (months of cash) | n/a | 3.5 | 205.2 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Aug 24 | Paul J Lytle | NQSO Common Stock | Grant | Acquire A | No | No | 8 | 234,971 | 1.88 mm | 0 |
14 Aug 24 | Daniel M Schmitt | RSU Common Stock | Grant | Acquire A | No | No | 0 | 544,111 | 0.00 | 0 |